0001958244-25-004262.txt : 20250820 0001958244-25-004262.hdr.sgml : 20250820 20250820173453 ACCESSION NUMBER: 0001958244-25-004262 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250820 DATE AS OF CHANGE: 20250820 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ascendis Pharma A/S CENTRAL INDEX KEY: 0001612042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36815 FILM NUMBER: 251237872 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP PROVINCE COUNTRY: G7 BUSINESS PHONE: 45 70 22 22 44 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP PROVINCE COUNTRY: G7 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: MIKKELSEN JAN MOLLER CENTRAL INDEX KEY: 0001180765 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 144 1 primary_doc.xml 144 0001180765 XXXXXXXX LIVE 0001612042 Ascendis Pharma A/S 001-36815 Tuborg Boulevard 12 Hellerup G7 DK-2900 45-70-22-22-44 Jan Moller Mikkelsen President and Chief Executive Officer American Depositary Shares Goldman Sachs & Co. LLC 200 West Street New York NY 10282 3000 578385 55635376 08/20/2025 NASD American Depositary Shares 08/20/2025 Warrant Exercise Issuer N 3000 08/20/2025 Cash Y The sale of shares relates to an exercise of warrants granted in 2016. 08/20/2025 Goldman Sachs & Co. LLC on behalf of Jan Moller Mikkelsen